2023
DOI: 10.1002/ejoc.202300374
|View full text |Cite
|
Sign up to set email alerts
|

Mechanochemical Desymmetrization of Unbiased Bis‐ and Tris‐alkynes to Access 3,5‐Isoxazoles‐Alkyne Adducts and Unsymmetrical Bis‐3,5‐isoxazoles**

Abstract: A mechanochemical desymmetrization of symmetrical bis‐ and tris‐alkynes by a controlled 1,3‐dipolar cycloaddition reaction using nitrile oxide dipoles (NOs). This operationally simple protocol allows access to 3,5‐isoxazole‐alkyne adducts from easily prepared or commercially available symmetrical bis‐ and tris‐alkynes in moderate to excellent yields. In addition, we have highlighted the synthetic utility of 3,5‐isoxazole‐alkyne by developing a route to access, for the first time, β‐ketoenamine‐alkyne derivativ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 86 publications
0
0
0
Order By: Relevance
“…[17] For the synthesis of N6-functionalized ImSyds, depending on which nucleophile reacts first with CDI, there are two possible strategies by desymmetrization of CDI. [18] Few years ago, an access to ImSyd-based prodrugs was developed thanks to carbonylimidazolium activation (Scheme 1a). [4] This CDI-based strategy gave access to a large number of N-carbonyl derivatives of ImSyds but required the activation of the imidazole moiety through a methylation extrastep, lacking of sustainability with the use of toxic and hazardous reagent (MeI) and solvents (DMF, acetonitrile or dichloromethane).…”
Section: Resultsmentioning
confidence: 99%
“…[17] For the synthesis of N6-functionalized ImSyds, depending on which nucleophile reacts first with CDI, there are two possible strategies by desymmetrization of CDI. [18] Few years ago, an access to ImSyd-based prodrugs was developed thanks to carbonylimidazolium activation (Scheme 1a). [4] This CDI-based strategy gave access to a large number of N-carbonyl derivatives of ImSyds but required the activation of the imidazole moiety through a methylation extrastep, lacking of sustainability with the use of toxic and hazardous reagent (MeI) and solvents (DMF, acetonitrile or dichloromethane).…”
Section: Resultsmentioning
confidence: 99%